8 research outputs found
Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence
During the detection of neck recurrence in patients with
Papillary Thyroid Carcinoma (PTC), sometimes it is difficult to distinguish metastatic from
inflammatory neck lymph nodes. The measurement of serum thyroglobulin (sTg) under thyroid
hormone suppression therapy, the presence of serum thyroglobulin antibodies (sAbTg), the diagnostic
whole body scan and cytology can give false negative results. Measurement of thyroglobulin in the
washout fluid from fine-needle aspiration biopsy (FNAB) of suspicious neck lymph nodes could
improve the diagnostic accuracy. Aim: To evaluate the usefulness of detecting Tg in lymph nodes (LTg)
suspicious by ultrasonography (US) and compare it to cytology. Patients and Methods: Between the
years 2004 and 2007 we prospectively studied 30 patients with PTC and cervical US findings of
suspicious recurrence. LTg was assayed in US guided FNAB used for cytology. Results: Sixteen out of
30 patients underwent surgery using as selective criteria an LTg higher than sTg or a positive cytology.
Surgery confirmed the presence of metastasis in all 15 patients with positive LTg (8 with positive
cytology) and in 1 patient with negative LTg and positive cytology (a case with undifferentiated thyroid
cancer). The sensitivity was 93.7% for LTg and 56.2% for cytology. We identified by LTg 3 of 6 patients
with undetectable sTg and positive sAbTg. Conclusions: The presence of LTg showed a higher
sensitivity than cytology for the detection of cervical lymph node metastasis. This method is useful even
in the presence of sAbT
Study and management of thyroid nodes by non specialist physicians: SOCHED consensus
The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection of nodules on ultrasound. The vast majority are benign and asymptomatic, staying stable over time. The clinical importance of studying a thyroid nodule is to exclude thyroid cancer, which occurs in 5 to 10% of the nodules. The Board of SOCHED (Chilean Society of Endocrinology and Diabetes) asked the Thyroid Study Group to develop a consensus regarding the diagnostic management of the thyroid nodule in Chile, aimed at non-specialist physicians and adapted to the national reality. To this end, a multidisciplinary group of 31 experts was established among university academics, active researchers with publications on the subject and prominent members of scientific societies of endocrinology, head and neck surgery, pathology and radiology. A total of 14 questions were developed with key aspects for the diagnosis and subsequent referral of patients with thyroid nodules, which were addressed by the participants. In those areas where the evidence was insufficient or the national reality had to be considered, the consensus opinion of the experts was used through the Delphi methodology. The consensus was approved by the SOCHED board for publication
A 10 gene classifier for indeterminate thyroid nodules: development and multicenter accuracy study
Background: In most of the world, diagnostic surgery remains the most frequent approach for indeterminate thyroid cytology. Although several molecular tests are available for testing in centralized commercial laboratories in the United States, there are no available kits for local laboratory testing. The aim of this study was to develop a prototype in vitro diagnostic (IVD) gene classifier for the further characterization of nodules with an indeterminate thyroid cytology.
Methods: In a first stage, the expression of 18 genes was determined by quantitative polymerase chain reaction (qPCR) in a broad histopathological spectrum of 114 fresh-tissue biopsies. Expression data were used to train several classifiers by supervised machine learning approaches. Classifiers were tested in an independent set of 139 samples. In a second stage, the best classifier was chosen as a model to develop a multiplexed-qPCR IVD prototype assay, which was tested in a prospective multicenter cohort of fine-needle aspiration biopsies.
Results: In tissue biopsies, the best classifier, using only 10 genes, reached an optimal and consistent performance in the ninefold cross-validated testing set (sensitivity 93% and specificity 81%). In the multicenter cohort of fine-needle aspiration biopsy samples, the 10-gene signature, built into a multiplexed-qPCR IVD prototype, showed an area under the curve of 0.97, a positive predictive value of 78%, and a negative predictive value of 98%. By Bayes' theorem, the IVD prototype is expected to achieve a positive predictive value of 64-82% and a negative predictive value of 97-99% in patients with a cancer prevalence range of 20-40%.
Conclusions: A new multiplexed-qPCR IVD prototype is reported that accurately classifies thyroid nodules and may provide a future solution suitable for local reference laboratory testing.Biomedical Research Consortium
13CTI-21526P2
CORFO 14IEAT-2867